(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

LUXNA BIOTECH

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

LUXNA BIOTECH

ST13

US500000079346600

Classe

1, 5, 40, 42

Pedido

79346600

Registro

7204020

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

26

Atualização mais recente

14/02/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 40, 42

Data de depósito

14/01/2022

Data de registro

31/10/2023

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

31/10/2023

Última transação

14/02/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

03

Localização do titular

JP

Examinador

FRENCH, CURTIS

Unidade examinadora

M60

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Luxna Biotech Co., Ltd.

Representantes

M. Scott Alprin Alprin Law Offices, P.C.

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 40Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Industrial chemicals; glue and adhesives for industrial purposes; plant growth regulating preparations; fertilizers; ceramic glazing in the nature of a dry chemical preparation for use in the manufacture of ceramics; Glaziers' priming putty; oil cement putty; higher fatty acids for industrial purposes; alkaline metals; alkaline-earth metals; non- metallic industrial minerals; chemical compositions for developing and printing photographs; reagent paper not for medical purposes; artificial sweeteners; flour and starch for industrial purposes; Unprocessed plastic in the form of powder or granules; groundwood pulp and chemiground wood pulps for manufacturing purposes; nucleic acid reagents not for medical purposes; chemical reagent for non-medical purposes for diagnosing molecular sequence of biological material such as nucleic acid; chemical reagents for non-medical purposes for use in isolation of ribonucleic acid in physical and chemical experiments; buffer solution and chemical reagent used to introduce molecules such as nucleic acids or their molecular assemblies into cells such as prokaryotic and eukaryotic cellsfor non-medical purposes; nucleic acid sequencesother than for medical or veterinary purposes; nucleic acids for scientific purposes; reagents for scientific purposes for use in nucleic acid isolation and purification; chemical reagent for analyzing nucleic acid in kitexcept for medical or veterinary use; chemical reagent for analyzing nucleic acidexcept for medical or veterinary use; reagent for detecting or quantifying nucleic acidexcept for medical or veterinary use; chemical diagnostic reagents for production and analysis of nucleic acidfor scientific and industrial use; nucleolytic enzyme for scientific and research purposes; reagent for detecting nucleic acid mutationexcept for medical or veterinary use; Industrial chemicals for nucleic acid analysis in kit form comprised of detection reagents; Industrial chemicals used as raw materials for conjugation with nucleic acid substances for introducing nucleic acid substances into cells; nucleic acid for use in the manufacture of pharmaceuticals; diagnostic reagents and preparationsexcept for medical or veterinary use; chemical reagents for use in genetic research for non-medical purposes; reagents for use in genetic researchexcept for medical or veterinary use; reagents for chemical and research purposes for non-medical purposes

Classe 5

Pharmaceutical preparations for use in treating liver diseasesrenal diseasecentral nerve system diseasesdegenerative nerve system diseasescerebral infarctioncentral hemorrhagespinal cord injuryautonomic nervous system diseasessensory organs diseasesneuromuscular diseasesskin diseasescardiovascular diseasesvascular and venous diseasesinfectious diseasescancerallergic diseasesrespiratory diseasesdiseases affecting digestive organsdiseases affecting uro-genitial and anal organschemically caused disorderschemical burn and side effect of anticancer drugsinflammation of braineyeearnosemouththroatheartlunglivergall bladderpancreasspleenstomachintestinestestisprostateovaryuteruskidneyurinary bladderskinmuscleboneneuronpain derived from injurydiseasesinflammationside effect of drugs and toxic reagent; Vermin destroying preparationsfungicidesherbicides; reagent paper for medical purposes; oiled paper for medical purposes; adhesive tapes for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; Capsules sold empty for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; materials for medical dressings; liquid bandages for skin wounds; breast-nursing pads; cotton swabs for medical use; Materials for dental fillings; Incontinence diapers; Infant diaper covers; fly catching paper; mothproofing paper; lacteal flour for babies; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; Nutritionally fortified beverages for babies for medical purposes; food for babies; dietary supplements for animals; semen for artificial insemination; nucleic acid medicine for use in treating liver diseasesrenal diseasecentral nerve system diseasesdegenerative nerve system diseasescerebral infarctioncentral hemorrhagespinal cord injuryautonomic nervous system diseasessensory organs diseasesneuromuscular diseasesskin diseasescardiovascular diseasesvascular and venous diseasesinfectious diseasescancerallergic diseasesrespiratory diseasesdiseases affecting digestive organsdiseases affecting uro-genitial and anal organschemically caused disorderschemical burn and side effect of anticancer drugsinflammation of braineyeearnosemouththroatheartlunglivergall bladderpancreasspleenstomachintestinestestisprostateovaryuteruskidneyurinary bladderskinmuscleboneneuronpain derived from injurydiseasesinflammationside effect of drugs and toxic reagent; reagents for detectionidentificationanalysisquantification of nucleic acid for medicine and medical diagnosis; diagnostic reagents for use in isolation of ribonucleic acid in clinical trials relating to medical services; reagent for detection of nucleic acid mutations for medical purposes; reagents for nucleic acid extraction for medical purposes; reagents for medical purposes for nucleic acid extraction in kit form comprised of detection reagents; reagents for medicalclinicalclinical examination and diagnosis relating to amplificationanalysis and labeling of nucleic aciddiagnostic reagents used as kits comprised of detection reagents; nucleic acid sequences for medical and veterinary purposes; nutritional supplements consisting primarily of nucleic acid in granularliquidtabletpowdersoft capsulecapsule form; pharmaceutical preparations and reagents for in vitro diagnostic; diagnostic biomarker reagents for medical purposes; reagents for use in medical genetic testing

Classe 40

Rental of chemical processing machines and apparatus; providing information relating to material treatment; cryopreservation services; custom manufacturing of nucleic acid materials or synthesis of nucleic acids; custom manufacture of chemical substances; custom manufacture of pharmaceuticals; custom manufacture of synthetic nucleic acids; custom manufacture or preparation of pharmaceuticals; custom extractionpurificationmanufacturing of pharmaceuticalsagricultural preparationsveterinary preparations; providing information relating to custom preparation and processing of chemicals; custom preparation and processing of chemicals; custom production and processing of proteins and chemicals

Classe 42

Providing meteorological information; meteorological information; architectural design; architectural services; surveying; geological surveys and research; geological research; designing for others of machinesapparatusinstruments and their partssystems composed of such machinesapparatus and instruments; Engineering design services; computer software designcomputer programmingmaintenance of computer software; computer programming; technological advice relating to computersautomobiles and industrial machines; testinginspection and research of pharmaceuticalscosmetics or foodstuffs; research on building construction and city planning; testing or research on prevention of pollution; testing or research on electricity; testing or research on civil engineering; testinginspection or research on agriculturelivestock breeding or fisheries; product testing and research on machinesapparatus and instruments; rental of measuring apparatus; rental of computers; installing computer programs on data networks; rental of laboratory apparatus and instruments; rental of technical drawing instruments; Pharmaceutical product development; providing adviceconsultancyinformation relating to development of pharmaceuticals; testinginspectionresearch relating to pharmaceuticalsproviding adviceconsultancyinformation relating thereto; providing information about medical and scientific research in the field of pharmaceuticals; pharmaceutical product evaluation; research and development services relating to medicines; testing of pharmaceuticals; research on the subject of pharmaceuticals; consultancy relating to pharmaceutical research and development; conducting clinical trials for other relating to pharmaceuticals; providing product information about the results of clinical trials for pharmaceuticals; testing of chemicals; development and test of chemical production methods; design of chemical manufacturing plants; advice relating to testinginspectionresearch of chemicals; providing information about testinginspectionresearch of chemicals; testinginspectionevaluationresearch of chemicals; testinginspectionresearch relating to chemicals; research and development of chemicals; custom pharmaceutical development; custom development of pharmaceuticals

Publicações

Histórico de despachos e eventos da marca no USPTO.

26 publicações encontradas

NREP

NEW REPRESENTATIVE AT IB RECEIVED

14/02/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

26/02/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/02/2024

FIMP

FINAL DISPOSITION PROCESSED

02/02/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

31/01/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

31/10/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

31/10/2023

GPNX

NOTIFICATION PROCESSED BY IB

21/08/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

15/08/2023

PUBO

PUBLISHED FOR OPPOSITION

15/08/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

02/08/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

02/08/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

26/07/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/07/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/07/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/07/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/07/2023

RFNT

REFUSAL PROCESSED BY IB

02/02/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/01/2023

RFRR

REFUSAL PROCESSED BY MPU

09/01/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

27/10/2022

CNRT

NON-FINAL ACTION WRITTEN

26/10/2022

DOCK

ASSIGNED TO EXAMINER

24/10/2022

MAFR

APPLICATION FILING RECEIPT MAILED

09/08/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/08/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

04/08/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace LUXNA BIOTECH ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.